Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers.
Cancer Cell
Sudhan, Dhivya R DR; Guerrero-Zotano, Angel A; Won, Helen H; González Ericsson, Paula P; Servetto, Alberto A; Huerta-Rosario, Mariela M; Ye, Dan D; Lee, Kyung-Min KM; Formisano, Luigi L; Guo, Yan Y; Liu, Qi Q; Kinch, Lisa N LN; Red Brewer, Monica M; Dugger, Teresa T; Koch, James J; Wick, Michael J MJ; Cutler, Richard E RE; Lalani, Alshad S AS; Bryce, Richard R; Auerbach, Alan A; Hanker, Ariella B AB; Arteaga, Carlos L CL